1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > IMS Country Review 2016: Japan

IMS Country Review 2016: Japan

  • July 2016
  • -
  • IMS Health
  • -
  • 82 pages

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Table Of Contents

IMS Country Review 2016: Japan
Table of Contents
SECTION 1: SYNOPSIS OF THE HEALTHCARE MARKET 5
MARKET TRENDS 5
HEALTHCARE PROVISION 5
PRESCRIBING POLICY 6
PRICING SYSTEM 7
REGULATORY ENVIRONMENT 8
INDUSTRY ENVIRONMENT 9
CHANNELS OF DISTRIBUTION 10
JAPAN DATA COLLECTION 11
SECTION 2: COUNTRY SALES PERFORMANCE AND TRENDS 12
FIGURE 1: COUNTRY RANKING AMONGST 30 MARKETS WORLDWIDE 12
FIGURE 2: AUDITED MARKET TREND 13
FIGURE 3: LEADING 35 LOCAL COMPANIES 14
FIGURE 4: LEADING 35 CORPORATIONS 16
FIGURE 5: MARKET SHARE BY CORPORATE NATIONALITY 18
FIGURE 6: LEADING 15 THERAPEUTIC CLASSES (LEVEL 3) 2015 19
FIGURE 7: 15 FASTEST-GROWING THERAPEUTIC CLASSES (LEVEL 3) 2015 20
FIGURE 8-22: LEADING 15 THERAPEUTIC CLASS PROFILES 21
FIGURE 8: A2B ANTIULCERANTS 21
FIGURE 9: A10N DPP-IV INHIBITOR A-DIABS 22
FIGURE 10: A10P SGLT2 INHIBITOR A-DIABS 23
FIGURE 11: A10S GLP-1 AGONIST A-DIABS 24
FIGURE 12: B1C PLATELET AGGR.INHIBITORS 25
FIGURE 13: B1F DIRECT FACTOR XA INHIBS 26
FIGURE 14: C9C ANGIOTEN-II ANTAG, PLAIN 27
FIGURE 15: C10A CHOLESTandTRIGLY.REGULATOR 28
FIGURE 16: D1A ANTIFUNGALS DERMATOLOGCL 29
FIGURE 17: J5B ANTIVIRALS EXCL ANTI-HIV 30
FIGURE 18: J7E VIRAL VACCINES 31
FIGURE 19: L1G MAB ANTINEOPLASTICS 32
FIGURE 20: L1H PROTEIN KINASE INH A-NEO 33
FIGURE 21: L4B ANTI-TNF PRODUCTS 34
FIGURE 22: M2A TOP A-RHEUMATICS and ANALG 35
FIGURE 23: LEADING 40 PRODUCTS 36
FIGURE 24: LEADING 40 NEW PRODUCTS 38
FIGURE 25: LEADING 15 PRODUCT FORMS 41
FIGURE 26: FASTEST GROWING 40 PRODUCTS SALES TRENDS 42
SECTION 3: APPENDICES 44
APPENDIX 1: AUDITED UNIVERSE 44
APPENDIX 2: COUNTRY SPECIFIC ALERTS 45
APPENDIX 3: MEASURE INDEX 48
APPENDIX 4: SALES DATA MEASURES 50
APPENDIX 5: *LATEST FACTORS 52
APPENDIX 6: QUARTERLY US$ EXCHANGE RATES BY COUNTRY 56
APPENDIX 7: CORPORATIONS 58
APPENDIX 8: PRODUCT NAMES 59
APPENDIX 9: THERAPIES 61
APPENDIX 10: EPHMRA ANATOMICAL THERAPEUTIC CLASSIFICATION 62

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering ...

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016

  • $ 1995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the joint venture deals and ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.